Home » RELIANCE TO PUMP IN $1 BN IN LIFE SCIENCES BUSINESS

RELIANCE TO PUMP IN $1 BN IN LIFE SCIENCES BUSINESS

June 1, 2006

The Mukesh Ambani-controlled Reliance Group is lining up big initiatives in the life sciences business this fiscal, by way of its arm Reliance Life Sciences (RLS).

The Financial Express (http://www.financialexpress.com/fe_full_story.php?content_id=128957)

KEYWORDS Daily International Pharma Alert

15Apr
Five Telltale Signs You’re Ready for an Electronic TMF System
21Apr
CDER’s Most Significant Guidance Priorities for 2021: Biosimilars/Biologics, Generics/Exclusivity, Real-World Evidence, Drug Development and Digital Health
26Apr
MAGI's Clinical Research vConference — Spring 2021
06May
The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

RELIANCE TO PUMP IN $1 BN IN LIFE SCIENCES BUSINESS

Upcoming Events

Five Telltale Signs You’re Ready for an Electronic TMF System

CDER’s Most Significant Guidance Priorities for 2021: Biosimilars/Biologics, Generics/Exclusivity, Real-World Evidence, Drug Development and Digital Health

MAGI's Clinical Research vConference — Spring 2021

The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

Biological Risk Evaluation and Management for Medical Devices

GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

Roche Receives CE Mark for Elecsys Cancer Test

Biogen and Bio-Thera Solutions Partner Over Actemra Biosimilar

Former Indivor Executive Seeks FDA Hearing to Avoid Debarment

FDA Clears Activ Surgical’s Imaging Module for ActivEdge Platform

The Revised ICH E8: A Guide to New Clinical Trial Requirements